Which drug is best for a patient with type 2 diabetes and heart failure?

被引：1
|
作者：
Clawson, Rebecca [1 ]
Weidman-Evans, Emily [1 ]
Fort, Ashley [1 ]
机构：
[1] LSUHSC Sch Allied Hlth Shreveport, Shreveport, LA USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 07期
关键词：
diabetes; heart failure; SGLT-2; inhibitors; HFrEF; thiazolidinediones; metformin; CARDIOVASCULAR OUTCOMES; METFORMIN; MELLITUS; MORTALITY; DISEASE;
D O I：
10.1097/01.JAA.0000743004.83284.cc
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure is twice as common in men with type 2 diabetes than those without it and is almost five times greater in women with diabetes. Ideally, effective treatment for one condition also will help with the other; certainly, clinicians should not prescribe a medication that will potentially worsen one of the conditions, if avoiding it is at all possible. This article reviews the effects of diabetes medications on heart failure outcomes.
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [31] Pioglitazone, SGLT2 inhibitors and their combination for primary prevention of cardiovascular disease and heart failure in type 2 diabetes: Real-world evidence from a nationwide cohort database
    Lo, Shih-Chang
    Kornelius, Edy
    Liao, Pei-Lun
    Huang, Jing-Yang
    Yang, Yi-Sun
    Huang, Chien-Ning
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 200
  • [32] Management of patient profiles with type 2 diabetes mellitus in Primary Care in Spain: CONTROVERTI2 Program
    Obaya Rebollar, J. C.
    Miravet Jimenez, S.
    Aranbarri Osoro, I
    Carraminana Barrera, F. C.
    Garcia Soidan, F. J.
    Cebrian Cuenca, A. M.
    MEDICINA DE FAMILIA-SEMERGEN, 2022, 48 (01): : 23 - 37
  • [33] Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond
    Sciacqua, Angela
    Succurro, Elena
    Armentaro, Giuseppe
    Miceli, Sofia
    Pastori, Daniele
    Rengo, Giuseppe
    Sesti, Giorgio
    HEART FAILURE REVIEWS, 2023, 28 (03) : 667 - 681
  • [34] Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis
    Tseng, Chin-Hsiao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (21):
  • [35] Differential therapy of heart failure - Which drug for which patient?
    Schillinger, W
    Hermann, HP
    Hasenfuss, G
    INTERNIST, 2004, 45 (12): : 1378 - +
  • [36] SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
    Gupta, Rahul
    Maitz, Theresa
    Egeler, David
    Mehta, Anila
    Nyaeme, Mark
    Hajra, Adrija
    Goel, Akshay
    Sreenivasan, Jayakumar
    Patel, Neel
    Aronow, Wilbert S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (08) : 479 - 486
  • [37] The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction
    Genuardi, Michael, V
    Mather, Paul J.
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2021, 15
  • [38] Management of type 2 diabetes in patients with heart failure
    Aguilar D.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 465 - 475
  • [39] Impact of empagliflozin in patients with diabetes and heart failure
    Pham, David
    Rocha, Natalia De Albuquerque
    McGuire, Darren K.
    Neeland, Ian J.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (02) : 144 - 151
  • [40] Personalized Management of Type 2 Diabetes
    Peter, Patricia R.
    Lupsa, Beatrice C.
    CURRENT DIABETES REPORTS, 2019, 19 (11)
12345